Wednesday, 4 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Nectar Lifesciences Merger & Restructuring

Nectar Lifesciences Limited has extended the completion date for the slump sale of its Empty Hard Gelatin Capsule business to Capnest Health Care Private Limited. The parties mutually agreed to extend the expected closing to July 31, 2026. Other transaction terms remain unchanged from the previous disclosure dated December 20, 2025.

Key figures
Execution periodon or before July 31, 2026
Source

NSE filing, NSE: NECLIFE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Nectar Lifesciences Ltd: key numbers

Share price
₹10.15
Market cap
₹227.6 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹-292.9 Cr
P/E (TTM)
-0.9×Sector 41.3×
Promoter holding
51.84%+0.00% QoQ
FII holding
0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Nectar Lifesciences Ltd

All →

Other merger & restructuring announcements

All →